Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug 15;205(4):892-898.
doi: 10.4049/jimmunol.2000554. Epub 2020 Jul 10.

A Case for Targeting Th17 Cells and IL-17A in SARS-CoV-2 Infections

Marika Orlov  1 , Pandora L Wander  2 , Eric D Morrell  3 , Carmen Mikacenic  3 , Mark M Wurfel  3
Affiliations
Review

A Case for Targeting Th17 Cells and IL-17A in SARS-CoV-2 Infections

Marika Orlov et al. J Immunol. .

Abstract

SARS-CoV-2, the virus causing COVID-19, has infected millions and has caused hundreds of thousands of fatalities. Risk factors for critical illness from SARS-CoV-2 infection include male gender, obesity, diabetes, and age >65. The mechanisms underlying the susceptibility to critical illness are poorly understood. Of interest, these comorbidities have previously been associated with increased signaling of Th17 cells. Th17 cells secrete IL-17A and are important for clearing extracellular pathogens, but inappropriate signaling has been linked to acute respiratory distress syndrome. Currently there are few treatment options for SARS-CoV-2 infections. This review describes evidence linking risk factors for critical illness in COVID-19 with increased Th17 cell activation and IL-17 signaling that may lead to increased likelihood for lung injury and respiratory failure. These findings provide a basis for testing the potential use of therapies directed at modulation of Th17 cells and IL-17A signaling in the treatment of COVID-19.

PubMed Disclaimer

Conflict of interest statement

Disclosures

The authors have no financial conflicts of interest.

Figures

FIGURE 1.
FIGURE 1.
Schematic showing Th17 differentiation and downstream signaling. Comorbidities of critical illness in COVID19 and their effects on Th17 signaling are depicted in blue. Inhibitors of Th17 signaling are depicted in orange.
See this image and copyright information in PMC

References

    1. Li R, Pei S, Chen B, Song Y, Zhang T, Yang W, and Shaman J. 2020. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science 368: 489–493. - PMC - PubMed
    1. Wu Z, and McGoogan JM. 2020. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA DOI: 10.1001/jama.2020.2648. - DOI - PubMed
    1. Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, Greninger AL, Pipavath S, Wurfel MM, Evans L, et al. 2020. Covid-19 in critically ill patients in the Seattle region - case series. N. Engl. J. Med 382: 2012–2022. - PMC - PubMed
    1. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, et al.; COVID-19 Lombardy ICU Network. 2020. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA 323: 1574–1581. - PMC - PubMed
    1. Petrilli CM, Jones SA, Yang J, Rajagopalan H, O’Donnell L, Chernyak Y, Tobin KA, Cerfolio RJ, Francois F, and Horwitz LI. 2020. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ 369: m1966. - PMC - PubMed

MeSH terms